MedPath

Helsinki University Central Hospital

Helsinki University Central Hospital logo
🇫🇮Finland
Ownership
Private
Established
1958-03-01
Employees
10K
Market Cap
-
Website
http://www.hus.fi

A Trial in Mini-invasive Pilonidal Sinus Disease Surgery

Not Applicable
Conditions
Pilonidal Disease
First Posted Date
2025-05-09
Last Posted Date
2025-05-09
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
188
Registration Number
NCT06964763
Locations
🇫🇮

HUS Vatsakeskus Abdominal Center of Helsinki University Hospital, Helsinki, Finland

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

Conditions
Non-alcoholic Fatty Liver Disease (NAFLD)
First Posted Date
2025-04-24
Last Posted Date
2025-04-24
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
30
Registration Number
NCT06942312
Locations
🇫🇮

Helsinki Central University Hospital, Helsinki, Uusimaa, Finland

The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland

Phase 2
Recruiting
Conditions
Kidney Failure
Paraproteinemias
Glomerulonephritis
Interventions
First Posted Date
2025-03-21
Last Posted Date
2025-03-21
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
30
Registration Number
NCT06889948
Locations
🇫🇮

Helsinki University Hospital, Helsinki, Finland

Effect of AI Assisted Documentation in Primary Health Care on Time Saving, Patient Satisfaction and Health Care Provider Satisfaction

Not Applicable
Not yet recruiting
Conditions
AI-assisted Documentation
First Posted Date
2025-02-20
Last Posted Date
2025-02-20
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
100
Registration Number
NCT06836258
Locations
🇫🇮

Western Uusimaa Welbeing services county, Espoo, Nummela, Kirkkonummi, Finland

Poly-L/D-lactide Implant (RegJoint) Versus Tendon Interposition for Trapeziometacarpal Inflammatory Arthritis: a 15-year Follow-up

Not Applicable
Completed
Conditions
Rheumatoid Arthritis (RA)
First Posted Date
2025-02-03
Last Posted Date
2025-02-03
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
21
Registration Number
NCT06804356
Locations
🇫🇮

Helsinki University Central Hospital, Helsinki, Finland

KF2024#1-trial: Esketamine Interaction Study

Phase 1
Not yet recruiting
Conditions
Drug Interactions
Food-drug Interaction
Interventions
First Posted Date
2024-12-10
Last Posted Date
2024-12-10
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
12
Registration Number
NCT06726382
Locations
🇫🇮

Department of Clinical Pharmacology, Helsinki, Finland

Intervention Effectiveness Study of BEtter AT LEarning (BEATLE)- Digital Neuropsychological Rehabilitation Program

Not Applicable
Recruiting
Conditions
Dyslexia, Developmental
Developmental Language Disorder
Specific Learning Disorder
Borderline Intellectual Functioning
First Posted Date
2024-12-03
Last Posted Date
2025-05-08
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
312
Registration Number
NCT06713863
Locations
🇫🇮

Pediatric Neurology, Helsinki University Hospital, Helsinki, Finland

🇫🇮

Phoniatrics, Helsinki University Hospital, Helsinki, Finland

Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer

Completed
Conditions
Oropharyngeal Cancers
Biomarker in Early Diagnosis
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
Periodontal Diseases
First Posted Date
2024-11-22
Last Posted Date
2024-11-22
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
107
Registration Number
NCT06701058
Locations
🇫🇮

Helsinki University Central Hospital, Helsinki, Uusimaa, Finland

Best Practice in the Management of Concha Bullosa in FESS Operation

Not Applicable
Active, not recruiting
Conditions
Sinusitis
Sinusitis Bacterial
Sinusitis Recurrent
Turbinate; Hypertrophy Mucous Membrane
Turbinate Hypertrophy
Concha Bullosa
Middle Turbinate
First Posted Date
2024-11-13
Last Posted Date
2024-11-13
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
62
Registration Number
NCT06687629
Locations
🇫🇮

Helsinki University Hospital Ear Clinic, Helsinki, Uusimaa, Finland

Effects of Vaginal Estrogen on Serum Estradiol During Aromatase Inhibitor Therapy in Breast Cancer Patients with Vulvovaginal Atrophy: a Prospective Trial

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Drug: Intravaginal estrogen during adjuvant letrozole
First Posted Date
2024-10-23
Last Posted Date
2024-10-23
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
20
Registration Number
NCT06654570
Locations
🇫🇮

HUS Comprehensive Cancer Center, Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath